This drug induces ferroptosis and inhibits malignant phenotypes of GC through the regulation of the miR-125b-5p/ signal transducer and activator of the transcription 3 (STAT3) axis, proving its potential for GC therapy [133]. Here, STAT3 is linked to gastric cancer.